Elanco Animal Health Incorporated (ELAN) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Elanco Animal Health Incorporated  (NYSE: ELAN)
 

Elanco Animal Health Incorporated Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Elanco Animal Health Incorporated's inventory turnover ratio sequentially decreased to 1.28 in the third quarter 2026, unsurprisingly, as the Elanco Animal Health Incorporated markets continue to deteriorate, and ELAN's faces growing challenges to bring down its inventories. Elanco Animal Health Incorporated's average inventory processing period in the Sep 30 2026 quarter, has increased to 285 days, from 283 days, in the Jun 30 2026 quarter.

Within Healthcare sector 285 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1041 in the second quarter 2026, to 1783.

ELAN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Elanco Animal Health Incorporated Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ELAN Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 6.44 % 5.93 % 7.85 % 10.36 % 4.66 %
Y / Y Cost of Sales Growth 2.83 % 7.95 % 15.13 % 10.78 % 7.72 %
Inventory Turnover Ratio (TTM) 1.28 1.29 1.29 1.27 1.26
ELAN's Total Ranking # 1783 # 1041 # 1041 # 626 #
Average inventory processing period 285 282 284 288 289
Seq. Inventory Growth 2.77 % 3.03 % -1.15 % 1.7 % 2.28 %
Seq. Cost of Sales Growth -4.39 % -2.73 % 5.59 % 4.72 % 0.38 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 80
Healthcare Sector # 286
Overall Market # 1783

Inventory Turnover Ratio Statistics
High Average Low
1.52 1.33 1.14
(Sep 30 2021)   (Sep 30 2023)



ELAN Company Profile >> Back to ELAN Efficiency Comparisons >> Compare ELAN Inventory Turnover Ratio to its Competitors

Financial Statements
Elanco Animal Health Incorporated's Inventories $ 1,818 Millions Visit ELAN's Balance sheet
Elanco Animal Health Incorporated's Cost of Revenues TTM $ 2,256 Millions Visit ELAN's Income Statement
What are ELAN's Sales? Visit ELAN's Sales by Segment

Other Inventory Turnover Ratios
Elanco Animal Health Incorporated's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ELAN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ELAN's Competitors
Inventory Turnover Ratio for ELAN's Suppliers
Inventory Turnover Ratio for ELAN's Customers

You may also want to know
ELAN's Sales Growth Rates ELAN's Pe Price to earnings ratio ELAN's Receivables Turnover Ratio ELAN's Stock Quote
ELAN's Net Income Growth Rates ELAN's Ps Price to Sales ratio ELAN's Sales per Employee ELAN's Asset Turnover Ratio
ELAN's Net Margin ELAN's Pb Price to Book ratio ELAN's Financial Strength Ratios ELAN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Angiodynamics Inc   2.50 $ 142.709  Millions$ 57  Millions
Pro dex Inc   2.45 $ 53.753  Millions$ 22  Millions
Illumina Inc   2.36 $ 1,458.000  Millions$ 618  Millions
Mirum Pharmaceuticals Inc   2.35 $ 59.684  Millions$ 25  Millions
Aquestive Therapeutics Inc   2.34 $ 16.928  Millions$ 7  Millions
Resmed Inc   2.33 $ 2,214.675  Millions$ 952  Millions
Beta Bionics Inc   2.31 $ 53.285  Millions$ 23  Millions
Merit Medical Systems Inc  2.25 $ 817.001  Millions$ 363  Millions
Bioventus Inc   2.24 $ 183.856  Millions$ 82  Millions
Johnson and Johnson  2.17 $ 32,222.000  Millions$ 14,824  Millions
Standard Biotools Inc   2.16 $ 39.539  Millions$ 18  Millions
Glaukos Corp  2.13 $ 131.180  Millions$ 62  Millions
Organon and Co   2.08 $ 2,859.000  Millions$ 1,371  Millions
Repligen Corp  2.07 $ 372.472  Millions$ 180  Millions
Boston Scientific Corporation  2.06 $ 6,502.000  Millions$ 3,153  Millions
Bausch and Lomb Corp  2.01 $ 1,986.000  Millions$ 990  Millions
Clearpoint Neuro Inc   1.98 $ 17.564  Millions$ 9  Millions
Intuitive Surgical Inc   1.91 $ 3,799.300  Millions$ 1,986  Millions
Indivior Pharmaceuticals Inc   1.88 $ 208.000  Millions$ 111  Millions
Tenet Healthcare Corp  1.88 $ 642.000  Millions$ 342  Millions

Date modified: 2026-11-07T13:23:47+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.